Curateq Biologics Receives Mhra Approval For Dazulbys
26/08/2025 07:37
Aug 26 (Reuters) - Aurobindo Pharma ARBN.NS: CURATEQ BIOLOGICS RECEIVES MHRA APPROVAL FOR DAZULBYS Source text: ID:nNSE1Ys71d Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11